M. Nizamudin, M. P. Kumar, A. Gautham, D. K. Sriram, and M. George, “Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD”, Int. J. Heal. Clin. Res., vol. 3, no. 5, pp. 85–89, Sep. 2020.